The role of ACER2 in intestinal sphingolipid metabolism and gastrointestinal cancers
Binggang Liu, Junfeng Zhou, Biao Jiang, Bing Tang, Ting Liu, Pengcheng Lei · 2024
Read The role of ACER2 in intestinal sphingolipid metabolism and gastrointestinal cancers by Binggang Liu, Junfeng Zhou, Biao Jiang, Bing Tang, Ting Liu, Pengcheng Lei (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11621088.txt.
Description
Binggang Liu and co-authors review an enzyme in 2024 tied to gut cancers. The enzyme, called ACER2 in the paper, sits in the metabolism of sphingolipids, fatty molecules that steer cell growth, death, and inflammation. It converts one such molecule into a building block for a potent signal that tumors exploit.
When the enzyme's activity goes off balance, cancers of the colon, stomach, and liver gain ground. Its pathway shapes immune responses and the life-or-death balance of tumor cells. The review gathers what is known about the enzyme in the intestine and argues that targeting its signaling could open new therapy routes for gut malignancies.
Catalog record
| CREATOR | Binggang Liu, Junfeng Zhou, Biao Jiang, Bing Tang, Ting Liu, Pengcheng Lei |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 21 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |